期刊文献+

改善胰岛素抵抗——预防和治疗2型糖尿病的关键 被引量:2

Improving insulin resistance-the key to prevention and treatment of type 2 diabetes
原文传递
导出
摘要 改善胰岛素抵抗是预防和治疗2型糖尿病的关键。针对胰岛素抵抗进行治疗能在更早的阶段更好地预防2型糖尿病、防止β细胞功能衰退,同时延缓动脉粥样硬化的进展。 Improving insulin resistance is the key to prevention and treatment of type 2 diabetes.Treatment aimed at insulin resistance can prevent type 2 diabetes in an earlier stage with a better effect, prevent the deterioration of β-cell function, and decrease the rate of the progression to atherosclerosis.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2011年第1期105-106,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 胰岛素抵抗 糖尿病 2型 预防和治疗 吡格列酮 Insulin resistance Diabetes Mellitus, type 2 Prevention and treatment Pioglitazone
  • 相关文献

参考文献13

  • 1DeFronzo RA,Tripathy D.Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.Diabetes Care,2009,32:S157-S163. 被引量:1
  • 2Perseghin G,Ghosh S,Gerow K,et al.Metabolic defects in lean nondiabetic offspring of NIDDM parents:a cross-sectional study.Diabetes,1997,46:1001-1009. 被引量:1
  • 3McCance DR,Pettitt DJ,Hanson RL,et al.Glucose,insulin concentrations,and obesity in childhood and adolescence as predictors of NIDDM.Diabetologia,1994,37:617-623. 被引量:1
  • 4DeFronzo RA,Barneji MA,Bray G,et al.ACTos NOW for the prevention of diabetes (ACT NOW) study.Late-breakingAbstractpresented at the 68th Annual Meeting of the American Diabetes Association.June 6-10,2008,San Francisco,CA. 被引量:1
  • 5Holman RR,Haffner SM,McMurray JJ,et al.Effect of nateglinide on the incidence of diabetes and cardiovascular events.N Engl J Med,2010,362:1463-1476. 被引量:1
  • 6Mazzone T,Meyer PM,Feinstein SB,et al.Effect of pioglitazone compared with glimepiride on carotid intimamedia thickness in type 2:a randomized trial.JAMA,2006,296:2572-2581. 被引量:1
  • 7Nissen SE,Nicholls SJ,Wolski K,et al.Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes:the periscope randomized controlled trial.JAMA,2008,299:1561-1573. 被引量:1
  • 8DeFronzo RA.From the triumvirate to the ominous octet:a new paradigm for the treatment of type 2 diabetes mellitus[Banting Lecture] .Diabetes,2009,58:773-795. 被引量:1
  • 9Dormandy JA,Charbonnel B,Eckland DJ,et al.Proactive investigators:secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitazone Clinical Trial in macroVascular Events):a randomized controlled trial.Lancet,2005,266:1279-1289. 被引量:1
  • 10Morrish NJ,Wang SL,Stevens LK,et al.Mortality and causes of death in the WHO multinational study of vascular disease in diabetes.Diabetologia,2001,44:S14-S21. 被引量:1

同被引文献34

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部